Related Experiment Video
Updated: Jun 13, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
Lipoprotein(a): from molecules to therapeutics
Valmore Bermúdez1, Nailet Arráiz, Daniel Aparicio
1Endocrine and Metabolic Diseases Research Center, University of Zulia, School of Medicine, Maracaibo, Venezuela. valmore@gmail.com
Lipoprotein (a) [Lp(a)] is a genetic risk factor for cardiovascular disease. Current treatments show limited success in reducing high Lp(a) plasma levels, necessitating further research.
Area of Science:
- Biochemistry
- Genetics
- Cardiology
Background:
- Lipoprotein (a) [Lp(a)], discovered in 1963, possesses unique apolipoprotein(a) linked to Apo B-100.
- Structural homology with plasminogen confers atherogenic and atherothrombotic properties.
- Elevated Lp(a) levels are strongly associated with coronary artery and cerebral vascular disorders.
Purpose of the Study:
- To review the significance of Lipoprotein (a) [Lp(a)] in cardiovascular health.
- To explore the genetic basis and population variations of Lp(a) levels.
- To assess the efficacy of current therapeutic interventions for hyper-Lp(a).
Main Methods:
- Review of case control studies and genetic research on Lp(a).
- Analysis of the genetic transmission and polymorphic gene variations influencing serum Lp(a) levels.
- Evaluation of various drug treatments and lifestyle interventions aimed at reducing Lp(a).
Main Results:
- Hyper-Lp(a) is a confirmed risk factor for premature cardiovascular disease.
- Lp(a) levels exhibit significant inter-individual, sex, and population variations due to genetic factors.
- Despite various interventions, no consistently effective therapeutic option for reducing plasma Lp(a) has been established.
Conclusions:
- Lipoprotein (a) [Lp(a)] is a significant, genetically determined risk factor for cardiovascular and cerebrovascular diseases.
- Understanding the genetic variations in Lp(a) is crucial for risk assessment.
- Effective therapeutic strategies for lowering Lp(a) remain a critical unmet need in clinical practice.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
What are Lipids?
Receptor-mediated Endocytosis
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
